celecoxib has been researched along with Cataract in 1 studies
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both rofecoxib and celecoxib were effective at inhibiting PCO formation in our ex vivo model." | 1.34 | Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition. ( Barden, CA; Chandler, HL; Colitz, CM; Kusewitt, DF; Lu, P, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandler, HL | 1 |
| Barden, CA | 1 |
| Lu, P | 1 |
| Kusewitt, DF | 1 |
| Colitz, CM | 1 |
1 other study available for celecoxib and Cataract
| Article | Year |
|---|---|
Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.
Topics: Animals; Apoptosis; Biomarkers; Cataract; Celecoxib; Cell Differentiation; Cell Movement; Cell Proli | 2007 |